Novartis AG is 145.2x more valuable than Mineralys Therapeutics, Inc. by market capitalization ($282.64 B vs $1.95 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MLYS | NVS |
|---|---|---|
| Market cap | $1.95 B | $282.64 B |
| US-listed rank | #2126 | #47 |
| Net income (latest FY) | -$154.65M | - |
| SEC filings | 350 | 947 |
Novartis AG is 145.2x more valuable than Mineralys Therapeutics, Inc. by market capitalization ($282.64 B vs $1.95 B).
Full pages: Mineralys Therapeutics, Inc. and Novartis AG, or browse the full rankings.